| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Pres., Novocure Oncology | President, Cns Cancers Us | Chief Development Officer
1 company
Leonard Frank X is an EVP, Pres., Novocure Oncology at NovoCure Ltd. Recent SEC Form 4 filings include 0 buys and 20 sells.
Estimated insider holdings value: $5.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 2, 2025 | NVCR Novocure Ltd | EVP, Pres., Novocure Oncology | Sell | 30,196 | $17.50 | $528,412.59 | -5.5% | -28.5% | -7.2% | |
| Mar 3, 2025 | NVCR Novocure Ltd | EVP, Pres., Novocure Oncology | Sell | 2,527 | $18.54 | $46,841.23 | -1.7% | -7.4% | -27.8% | |
| Feb 28, 2025 | NVCR Novocure Ltd | EVP, Pres., Novocure Oncology | Sell | 15,036 | $19.70 | $296,256.84 | -3.3% | +1.7% | -28.4% | |
| Nov 1, 2024 | NVCR Novocure Ltd | EVP, Pres., Novocure Oncology | Sell | 598 | $15.94 | $9,530.74 | -0.4% | +57.7% | -20.8% | |
| Mar 4, 2024 | NVCR Novocure Ltd | EVP, Pres., Novocure Oncology | Sell | 2,519 | $16.02 | $40,357.57 | -0.8% | +45.4% | +10.7% | |
| Feb 28, 2024 | NVCR Novocure Ltd | EVP, Pres., Novocure Oncology | Sell | 2,078 | $16.14 | $33,544.74 | -1.3% | +39.3% | +20.0% | |
| Mar 7, 2023 | NVCR Novocure Ltd | President, Cns Cancers Us | Sell | 13,609 | $75.55 | $1,028,164.59 | -5.4% | +10.2% | -77.8% | |
| Mar 3, 2023 | NVCR Novocure Ltd | President, Cns Cancers Us | Sell | 2,903 | $76.95 | $223,393.45 | -2.3% | -4.2% | -79.2% | |
| Mar 2, 2023 | NVCR Novocure Ltd | President, Cns Cancers Us | Sell | 4,107 | $75.38 | $309,577.72 | -3.4% | -4.4% | -78.4% | |
| Mar 1, 2023 | NVCR Novocure Ltd | President, Cns Cancers Us | Sell | 1,684 | $76.36 | $128,594.28 | -2.6% | -6.9% | -79.9% |